US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

GRAIL, Inc.

33.76

+4.0713.71%

Post-market: 33.850.0900+0.27%19:09 EDT

Volume:1.99M

Turnover:68.20M

Market Cap:1.14B

PE:-0.53

High:36.19

Open:32.48

Low:32.14

Close:29.69

Loading ...

Overview Company News Filings

GRAIL to Present New Data on Galleri® and its Methylation Platform at American Association for Cancer Research (AACR) Annual Meeting

Quest Diagnostics Revenue Rebound, Strategic Moves Fuel Outlook Confidence

This Cancer Test Could Become Routine -- and a Big Seller, Says Analyst -- Barrons.com

Canaccord Genuity Initiates GRAIL at Buy With $32 Price Target

MT Newswires Live

GRAIL Initiated at Buy by Canaccord Genuity

Grail initiated with a Buy at Canaccord

Have Insiders Sold GRAIL Shares Recently?

Simply Wall St.

QuidelOrtho Unveils Results Manager System to Streamline Testing

Is GRAIL, Inc. (GRAL) Among Jeff Bezos’ Investments in 2025?

Grail Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS

GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

GRAIL Partners With Actress Kate Walsh for Generation Possible to Raise Awareness of Multi-Cancer Early Detection Testing

GRAIL, Inc. (GRAL): Among the Best Performing Small Cap Stocks So Far In 2025

Why Grail (GRAL) Is Falling Today

Grail Inc trading resumes

Grail Shares Reverse Course From Premarket Gains; Last Down 9.6%

THOMSON REUTERS

Grail Inc trading halted, volatility trading pause

GRAIL to Present at TD Cowen 45th Annual Health Care Conference

Stock Track | GRAIL, Inc. Soars 7.01% in Pre-Market on Optimistic Outlook for Cancer Screening and Robotaxi Prospects

GRAIL Inc (GRAL) Q4 2024 Earnings Call Highlights: Revenue Surge and Strategic Partnerships ...

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/GRAL/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"GRAL","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GRAL\",,,,,undefined,":{"symbol":"GRAL","market":"US","secType":"STK","nameCN":"GRAIL, Inc.","latestPrice":33.76,"timestamp":1745438400000,"preClose":29.69,"halted":0,"volume":1988321,"hourTrading":{"tag":"盘后","latestPrice":33.85,"preClose":33.76,"latestTime":"19:09 EDT","volume":5824,"amount":197605.61184,"timestamp":1745449761026},"delay":0,"floatShares":22498691,"shares":33895246,"eps":-63.54,"marketStatus":"Post-Mkt","change":4.07,"latestTime":"04-23 19:15:59 EDT","open":32.48,"high":36.19,"low":32.14,"amount":68201219.67211,"amplitude":0.13641,"askPrice":33.8,"askSize":29,"bidPrice":33.33,"bidSize":1,"shortable":3,"etf":0,"ttmEps":-63.54,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1745452800000},"marketStatusCode":4,"adr":0,"exchange":"NASDAQ","adjPreClose":29.69,"preHourTrading":{"tag":"盘前","latestPrice":32.19,"preClose":29.69,"latestTime":"09:29 EDT","volume":12174,"amount":388313.71278,"timestamp":1745414999999},"postHourTrading":{"tag":"盘后","latestPrice":33.85,"preClose":33.76,"latestTime":"19:09 EDT","volume":5824,"amount":197605.61184,"timestamp":1745449761026},"volumeRatio":1.906891,"impliedVol":1.1674,"impliedVolPercentile":0.8689},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GRAL\",,,,,undefined,":{"symbol":"GRAL","floatShares":22498691,"roa":"-13.19%","roe":"-65.92%","lyrEps":-63.539968,"volumeRatio":1.906891,"shares":33895246,"dividePrice":0,"high":36.19,"amplitude":0.13641,"preClose":29.69,"low":32.14,"week52Low":12.33,"pbRate":"0.46","psRate":"9.11","week52High":63.99,"institutionHeld":0,"latestPrice":33.76,"committee":-0.933333,"eps":-63.54,"divideRate":0,"volume":1988321,"delay":0,"ttmEps":-63.54,"open":32.48,"prevYearClose":17.85,"prevWeekClose":27,"prevMonthClose":25.54,"prevQuarterClose":25.54,"fiveDayClose":25.935,"twentyDayClose":31.2,"sixtyDayClose":25.99},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GRAL\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2529856612","title":"GRAIL to Present New Data on Galleri® and its Methylation Platform at American Association for Cancer Research (AACR) Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2529856612","media":"PR Newswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529856612?lang=en_us&edition=fundamental","pubTime":"2025-04-23 04:01","pubTimestamp":1745352060,"startTime":"0","endTime":"0","summary":"Real-World Data in 100,000 Patients Further Support theGalleri Test's Ability to Simultaneously Screen for Multiple Cancers, as Well as its Accuracy of Cancer Signal of Origin Prediction to Support More Efficient Diagnostic Evaluations. Data From GRAIL's ctDNA-based Targeted Methylation Assay HighlightPotential to Identify Robust Signals of Promoter Methylation. MENLO PARK, Calif., April 22, 2025 /PRNewswire/ --GRAIL, Inc. , a healthcare company whose mission is to detect cancer early when it can be cured, will present new data highlighting the latest real-world evidence with the Galleri multi-cancer early detection  test and additional data from GRAIL's circulating tumor DNA -based targeted methylation platformat the American Association for Cancer Research  Annual Meeting in Chicago, April 25-30, 2025.This modeling analysis shows that individuals receiving a no cancer signal detectedMCED test result have a reduced risk of cancer diagnosis for one year post-blood draw; this risk incre","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/grail-present-data-galleri-methylation-200100376.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/grail-present-data-galleri-methylation-200100376.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["AFG","BK4217","GRAL","BK4588","BK4585","BK4107","BK4533","PSA","BK4117","BK4139","CLIA","BK4084"],"gpt_icon":0},{"id":"2529604539","title":"Quest Diagnostics Revenue Rebound, Strategic Moves Fuel Outlook Confidence","url":"https://stock-news.laohu8.com/highlight/detail?id=2529604539","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529604539?lang=en_us&edition=fundamental","pubTime":"2025-04-23 00:09","pubTimestamp":1745338168,"startTime":"0","endTime":"0","summary":"Quest Diagnostics Q1 2025 revenue rose to $2.65 billion with EPS of $2.21, exceeding expectations; full-year guidance for sales and EPS reaffirmed.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/general/biotech/25/04/44929366/quest-diagnostics-revenue-rebound-strategic-moves-fuel-outlook-confidence","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GRAL","DGX","FMS"],"gpt_icon":0},{"id":"2529353938","title":"This Cancer Test Could Become Routine -- and a Big Seller, Says Analyst -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2529353938","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529353938?lang=en_us&edition=fundamental","pubTime":"2025-04-22 04:47","pubTimestamp":1745268420,"startTime":"0","endTime":"0","summary":"Grail's cutting-edge cancer blood test has stirred investor excitement many times in the past few years. With the stock down 55% from its February peak, Canaccord Genuity issued a Buy recommendation on Monday.The company's Galleri product screens a blood sample for the genetic debris of cancer, which can appear long before any symptoms. Grail hopes its multicancer blood test will eventually become part of routine checkups.Grail made headlines five years ago, when it reported that a simple blood draw let it to find early signs of more than 50 kinds of cancer. Using genetic sequencing systems from Illumina, the test looks for telltale chemical tags on the DNA fragments from cancer cells.Early hopes for Grail's cancer test drew Illumina into clashes with antitrust regulators and its own stockholders that caused the ouster of Illumina's then chief executive.In 2021, Illumina CEO Francis deSouza pushed through an $8 billion buyout of Grail, in the teeth of antitrust challenges in the U.S. a","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","GRAL","ILMN","BK4121","BK4139","BK4585","BK4535","BK4548","BK4534"],"gpt_icon":0},{"id":"2529030268","title":"Canaccord Genuity Initiates GRAIL at Buy With $32 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2529030268","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529030268?lang=en_us&edition=fundamental","pubTime":"2025-04-21 20:23","pubTimestamp":1745238221,"startTime":"0","endTime":"0","summary":"Canaccord Genuity Initiates GRAIL at Buy With $32 Price Target","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["GRAL"],"gpt_icon":0},{"id":"2529872370","title":"GRAIL Initiated at Buy by Canaccord Genuity","url":"https://stock-news.laohu8.com/highlight/detail?id=2529872370","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529872370?lang=en_us&edition=fundamental","pubTime":"2025-04-21 19:07","pubTimestamp":1745233620,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/GRAL/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 21, 2025 07:07 ET (11:07 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GRAL","BK4139"],"gpt_icon":0},{"id":"2529387818","title":"Grail initiated with a Buy at Canaccord","url":"https://stock-news.laohu8.com/highlight/detail?id=2529387818","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529387818?lang=en_us&edition=fundamental","pubTime":"2025-04-21 17:25","pubTimestamp":1745227507,"startTime":"0","endTime":"0","summary":"Canaccord analyst Kyle Mikson initiated coverage of Grail (GRAL) with a Buy rating and $32 price target Published first on TheFly – the ultimate so...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/grail-initiated-with-a-buy-at-canaccord?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/grail-initiated-with-a-buy-at-canaccord?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GRAL","BK4139"],"gpt_icon":0},{"id":"2520583151","title":"Have Insiders Sold GRAIL Shares Recently?","url":"https://stock-news.laohu8.com/highlight/detail?id=2520583151","media":"Simply Wall St.","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520583151?lang=en_us&edition=fundamental","pubTime":"2025-03-16 22:12","pubTimestamp":1742134323,"startTime":"0","endTime":"0","summary":"We'd be surprised if GRAIL, Inc. ( NASDAQ:GRAL ) shareholders haven't noticed that the CEO & Director, Robert Ragusa...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-gral/grail/news/have-insiders-sold-grail-shares-recently","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["GRAL","BK4139"],"gpt_icon":1},{"id":"2519382663","title":"QuidelOrtho Unveils Results Manager System to Streamline Testing","url":"https://stock-news.laohu8.com/highlight/detail?id=2519382663","media":"Zacks","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519382663?lang=en_us&edition=fundamental","pubTime":"2025-03-14 22:00","pubTimestamp":1741960800,"startTime":"0","endTime":"0","summary":"QuidelOrtho QDEL recently launched the Results Manager System, a cutting-edge solution designed to streamline diagnostic data management and improve workflow efficiency in laboratories. This innovative system enhances connectivity, enabling seamless integration of test results from multiple sources for faster and more accurate decision-making.With the Results Manager System, QuidelOrtho aims to optimize laboratory operations and support better patient outcomes. By simplifying data handling and reducing manual processes, the system reinforces QuidelOrtho’s commitment to advancing diagnostic solutions for healthcare providers.QDEL’s Results Manager System is designed to enhance the efficiency of laboratory workflows by centralizing and streamlining diagnostic data management. It integrates results from multiple testing instruments, providing a unified view of patient diagnostics. This connectivity reduces manual data entry, minimizing errors and ensuring faster, more accurate reporting. ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/quidelortho-unveils-results-manager-system-140000925.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0122379950.USD","LU1923623000.USD","LU2125909247.SGD","SG9999002224.SGD","LU0823416689.USD","LU1951200564.SGD","LU0266013472.USD","SG9999002232.USD","IE00BFTCPJ56.SGD","SG9999004303.SGD","LU1914381329.SGD","SGXZ23171101.USD","LU2433249047.HKD","LU1023059063.AUD","BK4568","LU1989763690.USD","BK4581","LU1721429741.USD","LU1989763427.SGD","QDEL","BK4533","GRAL","LU1691799644.USD","IE00BJJMRZ35.SGD","LU2468319806.SGD","IE00B2B36J28.USD","LU1951198990.SGD","LU1061106388.HKD","BK4504","LU2133065610.SGD","BK4198","BK4588","BK4566","BK4082","IE0002141913.USD","LU2089984988.USD","LU1057294990.SGD","LU2125909593.SGD","IE00BJT1NW94.SGD","IE00B4R5TH58.HKD","LU2237957902.USD","LU1923622614.USD","BK4585","LU2112291526.USD","BK4139","LU0234572021.USD","ABT","LU0170899867.USD","IE0009355771.USD","HOLX"],"gpt_icon":0},{"id":"2516065945","title":"Is GRAIL, Inc. (GRAL) Among Jeff Bezos’ Investments in 2025?","url":"https://stock-news.laohu8.com/highlight/detail?id=2516065945","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516065945?lang=en_us&edition=fundamental","pubTime":"2025-03-04 01:30","pubTimestamp":1741023028,"startTime":"0","endTime":"0","summary":"We recently compiled a list of the Jeff Bezos Investments in 2025: 12 Companies Bezos Is Investing In.In this article, we are going to take a look at where GRAIL, Inc.  stands against the other companies Bezos is investing in.Since leaving his position as CEO of Amazon in 2021, Jeff Bezos has been quite active. He has been investing in real estate and companies, staying involved with Amazon and Blue Origin, and becoming close to President-elect Trump. “I’ve actually never worked harder,” he told the New York Times last December.Jeff Bezos has directly invested in at least 108 startups across all industries since 1998, when he was reported to have invested $250,000 into Google. Although he does not publish his returns nor do the firms in which he invests, he has made early bets on several companies that have gone on to launch some of the most high-profile tech IPOs in the recent decade.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/grail-inc-gral-among-jeff-173028890.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["GRAL","NQmain","QID","PSQ",".IXIC","SQQQ","TQQQ","MNQmain","USAW.SI","TSYW.SI","USJW.SI","QLD","BK4139","NVIW.SI"],"gpt_icon":1},{"id":"2514867747","title":"Grail Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2514867747","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514867747?lang=en_us&edition=fundamental","pubTime":"2025-02-27 05:05","pubTimestamp":1740603905,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250226:nTUA2FWXFW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GRAL","BK4139"],"gpt_icon":0},{"id":"2514985418","title":"GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2514985418","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514985418?lang=en_us&edition=fundamental","pubTime":"2025-02-27 05:05","pubTimestamp":1740603900,"startTime":"0","endTime":"0","summary":"MENLO PARK, Calif., Feb. 26, 2025 /PRNewswire/ -- GRAIL, Inc. , a healthcare company whose mission is to detect cancer early when it can be cured, today announced that it has granted equity awards in the form of restricted stock units  underlying an aggregate of 108,450 shares of GRAIL's common stock to 15 recently hired non-executive employees as an inducement material to their acceptance of employment with GRAIL. The employment inducement awards were granted under GRAIL's Inducement Equity Incentive Plan and related form of restricted stock award agreement in accordance with Nasdaq Listing Rule 5635.The inducement plan is used exclusively for the grant of equity awards to individuals who were not previously employees of GRAIL, or following a bona fide period of non-employment, as an inducement material to such individuals entering into employment with GRAIL, pursuant to Nasdaq Listing Rule 5635.The RSUs vest overan approximately four year period, with 25% of the award vesting Feb. 28","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/grail-announces-inducement-grants-under-210500869.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/grail-announces-inducement-grants-under-210500869.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2095319765.USD","LU2210149790.SGD","NDAQ","BK4139","BK4112","IE00BKPKM429.USD","BK4585","IE00B3QW5Z07.USD","BK4588","IE00BGHQF748.EUR","IE00B64PRP62.GBP",".IXIC","GRAL","LU2210150020.SGD"],"gpt_icon":0},{"id":"2514092312","title":"GRAIL Partners With Actress Kate Walsh for Generation Possible to Raise Awareness of Multi-Cancer Early Detection Testing","url":"https://stock-news.laohu8.com/highlight/detail?id=2514092312","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514092312?lang=en_us&edition=fundamental","pubTime":"2025-02-25 22:00","pubTimestamp":1740492000,"startTime":"0","endTime":"0","summary":"Walsh has seen the devastating impact a cancer diagnosis can have through each of her parents' cancer journeys. These experiences led to her passion for living a healthy lifestyle, her commitment to getting her recommended cancer screenings and her advocacy for new health advances.Cancer remains a major public health crisis and nearly half (46%) of Americans aged 50-75 are worried about a cancer diagnosis.2,3 It's critical to get the cancer screenings your doctor recommends, such as mammograms and colonoscopies. Yet, only fivetypes of cancer have recommended screening tests and about 70% of cancer deaths are caused by cancers with no recommended screening tests.2,4 When cancer is diagnosed early, before it has time to spread, the overall 5-year survival rate is fourtimes higher than when cancer is diagnosed late.5. More information about Generation Possible can be found at GenPossible.com, including Walsh's personal connection to cancer, details about MCED testing and access to importa","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/grail-partners-actress-kate-walsh-140000995.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/grail-partners-actress-kate-walsh-140000995.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4121","SEER","BK4139","GRAL"],"gpt_icon":0},{"id":"2514770362","title":"GRAIL, Inc. (GRAL): Among the Best Performing Small Cap Stocks So Far In 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2514770362","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514770362?lang=en_us&edition=fundamental","pubTime":"2025-02-25 03:02","pubTimestamp":1740423723,"startTime":"0","endTime":"0","summary":"We recently compiled a list of the 12 Best Performing Small Cap Stocks So Far in 2025. In this article, we are going to take a look at where GRAIL, Inc.  stands against the other small cap stocks.On February 14, Stacey Sears, portfolio manager at Emerald Advisors, joined 'Squawk Box' on CNBC to share her insights on the market's performance in early February. She thinks that small-cap earnings data is encouraging. Despite various news events, which include inflation data and tariff announcements, she thinks that the market has handled the developments well. Michael Hartnett of Bank of America suggests that the recent hot CPI could be a blessing in disguise as it might lead President Trump to adopt more cautious policies regarding tariffs and immigration. But Sears emphasized that her team is not overly concerned about inflation levels at present. They believe that while there has been an uptick in some inflation indicators like PPI elements, these don't significantly impact Personal Co","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/grail-inc-gral-among-best-190203352.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["TSYW.SI","SQQQ","QLD","GRAL","SOFR","NVIW.SI","NQmain","QID","TQQQ",".IXIC","BK4139","MNQmain","USAW.SI","USJW.SI","PSQ"],"gpt_icon":1},{"id":"2513911332","title":"Why Grail (GRAL) Is Falling Today","url":"https://stock-news.laohu8.com/highlight/detail?id=2513911332","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513911332?lang=en_us&edition=fundamental","pubTime":"2025-02-21 23:00","pubTimestamp":1740150017,"startTime":"0","endTime":"0","summary":"Grail's  stock is dropping 6% after the company reported fourth-quarter revenue above analysts' average estimate and noted that Tricare, a large health insurance provider, had decided to provide coverage of Grail's Galleri test for a portion of its members. However, the company's 2024 screening revenue growth came in at the midpoint of its previous guidance range, and some investors may have expected the firm to report screening sales above that level.30 Most Important AI Stocks According to BlackRock Disclosure: The author owns shares of GRAL but has no intention of trading them in the next 48 hours. This article is originally published at Insider Monkey.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/why-grail-gral-falling-today-150017416.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","GRAL"],"gpt_icon":1},{"id":"2513229955","title":"Grail Inc trading resumes","url":"https://stock-news.laohu8.com/highlight/detail?id=2513229955","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513229955?lang=en_us&edition=fundamental","pubTime":"2025-02-21 22:40","pubTimestamp":1740148838,"startTime":"0","endTime":"0","summary":"09:39 EST Grail (GRAL) Inc trading resumes Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Tr...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/grail-inc-trading-resumes-3?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/grail-inc-trading-resumes-3?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GRAL","BK4139"],"gpt_icon":0},{"id":"2513295238","title":"Grail Shares Reverse Course From Premarket Gains; Last Down 9.6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513295238","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513295238?lang=en_us&edition=fundamental","pubTime":"2025-02-21 22:35","pubTimestamp":1740148530,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250221:nFWN3PC0Z0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","GRAL"],"gpt_icon":0},{"id":"2513064295","title":"Grail Inc trading halted, volatility trading pause","url":"https://stock-news.laohu8.com/highlight/detail?id=2513064295","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513064295?lang=en_us&edition=fundamental","pubTime":"2025-02-21 22:35","pubTimestamp":1740148527,"startTime":"0","endTime":"0","summary":"09:34 EST Grail (GRAL) Inc trading halted, volatility trading pause Published first on TheFly – the ultimate source for real-time, market-moving br...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/grail-inc-trading-halted-volatility-trading-pause-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/grail-inc-trading-halted-volatility-trading-pause-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GRAL","BK4139"],"gpt_icon":0},{"id":"2513295854","title":"GRAIL to Present at TD Cowen 45th Annual Health Care Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2513295854","media":"PR Newswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513295854?lang=en_us&edition=fundamental","pubTime":"2025-02-21 22:00","pubTimestamp":1740146400,"startTime":"0","endTime":"0","summary":"MENLO PARK, Calif., Feb. 21, 2025 /PRNewswire/ -- GRAIL, Inc. , a healthcare company whose mission is to detect cancer early when it can be cured, today announced that company management will present at the TD Cowen 45th Annual Health Care Conference in Boston on Tuesday, Mar. 4 at 9:10 a.m. ET.About GRAILGRAIL is a healthcare company whose mission is to detect cancer early, when it can be cured. GRAIL is focused on alleviating the global burden of cancer by using the power of next-generation sequencing, population-scale clinical studies, and state-of-the-art machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. GRAIL's targeted methylation-based platform can support the continuum of care for screening and precision oncology, including multi-cancer early detection in symptomatic patients, risk stratification, minimal residual disease detection, biomarker subtyping, treatment and recurrence monitoring. GRAIL is headquartered in","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/grail-present-td-cowen-45th-140000827.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/grail-present-td-cowen-45th-140000827.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4127","BK4207","GRAL","BK4566","BK4585","TD","COWN","BK4139"],"gpt_icon":0},{"id":"1144662197","title":"Stock Track | GRAIL, Inc. Soars 7.01% in Pre-Market on Optimistic Outlook for Cancer Screening and Robotaxi Prospects","url":"https://stock-news.laohu8.com/highlight/detail?id=1144662197","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1144662197?lang=en_us&edition=fundamental","pubTime":"2025-02-21 17:32","pubTimestamp":1740130351,"startTime":"0","endTime":"0","summary":"GRAIL, Inc.  saw its stock surge 7.01% in the pre-market trading session on Friday, driven by an optimistic outlook from analysts regarding the company's prospects in the cancer screening and early detection market, as well as its robotaxi project.Analysts are bullish on GRAIL's potential in the liquid biopsy market, with its Galleri multi-cancer early detection test showing promising results in clinical trials. The company's recent partnerships with leading healthcare providers have fueled expe","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["GRAL"],"gpt_icon":0},{"id":"2513237142","title":"GRAIL Inc (GRAL) Q4 2024 Earnings Call Highlights: Revenue Surge and Strategic Partnerships ...","url":"https://stock-news.laohu8.com/highlight/detail?id=2513237142","media":"GuruFocus.com","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513237142?lang=en_us&edition=fundamental","pubTime":"2025-02-21 15:15","pubTimestamp":1740122135,"startTime":"0","endTime":"0","summary":"For the complete transcript of the earnings call, please refer to the full earnings call transcript.GRAIL Inc  reported a 26% increase in revenue for Q4 2024, reaching $38.3 million compared to Q4 2023.The company achieved a 45% year-over-year growth in US gallery revenue, selling over 137,000 gallery tests.The US military's TriCare Health Insurance Program added the gallery test as a covered benefit for eligible patients, expanding potential market reach.The company has extended its cash runway into 2028, providing financial stability to achieve major milestones, including FDA submissions.Q: How does the recent collaboration with Quest Diagnostics and the Tricare news impact your 2025 guidance?","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/grail-inc-gral-q4-2024-071535551.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["DGX","GRAL"],"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":1,"totalSize":81,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GRAL\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-02-20","symbol":"GRAL","fiscalQuarterEnding":"2024/12","expectedEps":-4.41,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1740027600000,"reportTimeType":"post","actualEps":-1.86},{"market":"US","date":"2024-11-12","symbol":"GRAL","fiscalQuarterEnding":"2024/09","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"post","actualEps":-3.94},{"market":"US","date":"2024-08-13","symbol":"GRAL","fiscalQuarterEnding":"2024/06","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1723521600000,"reportTimeType":"post","actualEps":-5.3},{"market":"US","date":"2024-06-25","symbol":"GRAL","reason":null,"defaultRemindTime":1719322200000,"announcedDate":"2024-06-05","type":"delisting","dateTimestamp":1719288000000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GRAL\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GRAL\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0,"hold":1,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":1,"analysts":3,"updateTime":1732766400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/GRAL\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"GRAL","date":"2025-04-22","current":-0.441791,"percent":0.231579,"low":-0.873079,"twenty":-0.453995,"median":-0.283251,"eighty":-0.151734,"high":-0.135365,"avg":-0.31981,"sd":0.170179,"marketCap":895512399},"quantilePoints":[{"date":"2024-06-12","current":-0.243184,"twenty":-0.243184,"median":-0.243184,"eighty":-0.243184,"marketCap":362571424},{"date":"2024-06-28","current":-0.269888,"twenty":-0.264547,"median":-0.256536,"eighty":-0.248525,"marketCap":402385270},{"date":"2024-07-05","current":-0.275763,"twenty":-0.275763,"median":-0.271757,"eighty":-0.266328,"marketCap":411144316},{"date":"2024-07-12","current":-0.259385,"twenty":-0.273627,"median":-0.266328,"eighty":-0.249504,"marketCap":386725157},{"date":"2024-07-15","current":-0.263657,"twenty":-0.273022,"median":-0.264992,"eighty":-0.25148,"marketCap":393095372},{"date":"2024-08-02","current":-0.296236,"twenty":-0.274909,"median":-0.266328,"eighty":-0.253456,"marketCap":441668264},{"date":"2024-08-09","current":-0.310656,"twenty":-0.300615,"median":-0.272114,"eighty":-0.260667,"marketCap":463167741},{"date":"2024-08-16","current":-0.170902,"twenty":-0.29588,"median":-0.2706,"eighty":-0.248276,"marketCap":492749978},{"date":"2024-08-23","current":-0.178117,"twenty":-0.292284,"median":-0.264992,"eighty":-0.180551,"marketCap":513552907},{"date":"2024-08-30","current":-0.159595,"twenty":-0.28292,"median":-0.259385,"eighty":-0.170708,"marketCap":460148373},{"date":"2024-09-06","current":-0.145057,"twenty":-0.275763,"median":-0.247457,"eighty":-0.162201,"marketCap":418232023},{"date":"2024-09-13","current":-0.145918,"twenty":-0.275336,"median":-0.18151,"eighty":-0.152854,"marketCap":420715955},{"date":"2024-09-20","current":-0.149365,"twenty":-0.273627,"median":-0.178117,"eighty":-0.150075,"marketCap":430651682},{"date":"2024-09-27","current":-0.146457,"twenty":-0.273022,"median":-0.170741,"eighty":-0.146026,"marketCap":422268412},{"date":"2024-10-04","current":-0.135365,"twenty":-0.270458,"median":-0.165733,"eighty":-0.14454,"marketCap":390287790},{"date":"2024-10-11","current":-0.140319,"twenty":-0.269176,"median":-0.160133,"eighty":-0.142925,"marketCap":404570398},{"date":"2024-10-18","current":-0.152918,"twenty":-0.265794,"median":-0.156041,"eighty":-0.143463,"marketCap":440897901},{"date":"2024-10-25","current":-0.13978,"twenty":-0.263443,"median":-0.155556,"eighty":-0.143463,"marketCap":403017941},{"date":"2024-10-31","current":-0.146672,"twenty":-0.262589,"median":-0.153942,"eighty":-0.142688,"marketCap":422889395},{"date":"2024-11-08","current":-0.160456,"twenty":-0.259385,"median":-0.152918,"eighty":-0.142796,"marketCap":462632305},{"date":"2024-11-15","current":-0.250879,"twenty":-0.250879,"median":-0.154641,"eighty":-0.143442,"marketCap":531228205},{"date":"2024-11-22","current":-0.259924,"twenty":-0.250879,"median":-0.156041,"eighty":-0.143549,"marketCap":550380645},{"date":"2024-11-29","current":-0.277697,"twenty":-0.262044,"median":-0.156472,"eighty":-0.143635,"marketCap":588013510},{"date":"2024-12-06","current":-0.355611,"twenty":-0.27003,"median":-0.160025,"eighty":-0.14426,"marketCap":752993300},{"date":"2024-12-13","current":-0.329745,"twenty":-0.275763,"median":-0.161318,"eighty":-0.144928,"marketCap":698224042},{"date":"2024-12-20","current":-0.271984,"twenty":-0.27776,"median":-0.165841,"eighty":-0.145746,"marketCap":575917232},{"date":"2024-12-27","current":-0.308005,"twenty":-0.287312,"median":-0.170741,"eighty":-0.145918,"marketCap":652190984},{"date":"2025-01-03","current":-0.284362,"twenty":-0.289787,"median":-0.175532,"eighty":-0.146134,"marketCap":602125834},{"date":"2025-01-10","current":-0.280236,"twenty":-0.294514,"median":-0.180594,"eighty":-0.1465,"marketCap":593389633},{"date":"2025-01-17","current":-0.276189,"twenty":-0.293978,"median":-0.222157,"eighty":-0.146801,"marketCap":584821436},{"date":"2025-01-24","current":-0.412102,"twenty":-0.295346,"median":-0.234852,"eighty":-0.147318,"marketCap":872612048},{"date":"2025-01-31","current":-0.500013,"twenty":-0.298484,"median":-0.241319,"eighty":-0.14818,"marketCap":1058760325},{"date":"2025-02-07","current":-0.523498,"twenty":-0.307212,"median":-0.249504,"eighty":-0.148826,"marketCap":1108489468},{"date":"2025-02-14","current":-0.83436,"twenty":-0.31102,"median":-0.255132,"eighty":-0.149365,"marketCap":1766728591},{"date":"2025-02-21","current":-0.791697,"twenty":-0.321747,"median":-0.260916,"eighty":-0.149365,"marketCap":1604772870},{"date":"2025-02-28","current":-0.656882,"twenty":-0.34371,"median":-0.263657,"eighty":-0.149709,"marketCap":1331502572},{"date":"2025-03-07","current":-0.559345,"twenty":-0.359577,"median":-0.270244,"eighty":-0.149795,"marketCap":1133795978},{"date":"2025-03-14","current":-0.450152,"twenty":-0.414561,"median":-0.273627,"eighty":-0.15014,"marketCap":912460022},{"date":"2025-03-21","current":-0.465034,"twenty":-0.450921,"median":-0.275763,"eighty":-0.150484,"marketCap":942626791},{"date":"2025-03-28","current":-0.47791,"twenty":-0.468947,"median":-0.276427,"eighty":-0.150807,"marketCap":968726130},{"date":"2025-04-04","current":-0.416039,"twenty":-0.465703,"median":-0.277856,"eighty":-0.15113,"marketCap":843313720},{"date":"2025-04-11","current":-0.380338,"twenty":-0.459122,"median":-0.280236,"eighty":-0.151281,"marketCap":770947370},{"date":"2025-04-17","current":-0.443129,"twenty":-0.455455,"median":-0.281347,"eighty":-0.151562,"marketCap":898224019},{"date":"2025-04-22","current":-0.441791,"twenty":-0.453995,"median":-0.283251,"eighty":-0.151734,"marketCap":895512399}],"updateTime":1745432739628}}}